2019 Confirmed Attendees

Job Title Company Name Country
Investment Analyst 4Bio Capital United Kingdom
Investment Director 4BIO Ventures Management Ltd United Kingdom
President & Chief Executive Officer Acasti Pharma Canada
Senior Partner Accequa Sweden
CEO Actimed Therapeutics United Kingdom
Operating Partner Advent Life Sciences United Kingdom
Associate Advent Life Sciences United Kingdom
Chief Executive Officer AIMM Therapeutics BV The Netherlands
Partner Albion Capital United Kingdom
Partner Albion Capital United Kingdom
Director Albion Technology & General VCT plc United Kingdom
CFO Allecra Therapeutics GmbH Germany
Senior Financial Analyst Alpha Blue Ocean United Kingdom
Junior Analyst Alpha Blue Ocean United Kingdom
CEO ALSA Holdings United Kingdom
Investment Director ALSA Holdings United Kingdom
Investment Director ALSA Holdings United Kingdom
Principal Amadeus Capital Partners United Kingdom
Head of sourcing aMoon ventures Israel
CEO AMRA Medical Sweden
Principal Apollo Ventures United Kingdom
Scientific Advisor Areterial Capital Management Monaco
angel arrowfield capital United Kingdom
CEO Artelo Biosciences United States
Scientic Advisor Arterial Capital Management Monaco
CFO ASIT Biotech Belgium
Investor AV8 Ventures United Kingdom
Partner BB Pureos Bioventures Switzerland
Managing Partner BB Pureos Bioventures Switzerland
CEO Beoro Therapeutics Germany
Investor BioCity United Kingdom
CEO BioFidelity United Kingdom
President and Chief Executive Officer BioInvent International Sweden
Investment Manager BioMedPartners Switzerland
Investment Consultant Bioscience Managers United Kingdom
Investor Director Bioscience Managers United Kingdom
Managin Partner BioSeed Capital United Kingdom
CEO Black Belt Therapeutics United Kingdom
VP BNY Mellon United Kingdom
CFO Bone Therapeutics Belgium
President & CEO Brainstorm Cell Therapeutics Israel
Executive Vice President and Chief Financial Officer BrainStorm Cell Therapeutics United States
Associate Partner Breed Reply United Kingdom
partner Bridge Valley Ventures United Kingdom
Investor Business Angel United Kingdom
President & CEO Caladrius Biosciences United States
VP, Investor Relations & Corporate Communications Caladrius Biosciences United States
CEO Calcivis Ltd United Kingdom
Partner Cambridge Innovation Capital plc United Kingdom
CEO carocellbio.com United Kingdom
Managing Director Cascara Ventures Bvba Belgium
CEO CaSRevolution Srl Italy
Chief Executive Officer Castor EDC The Netherlands
CEO Catalytic Life  United States
Investment Analyst Catapult Ventures United Kingdom
CEO Censo Bio United Kingdom
Founder Cleara Biotech B.V. The Netherlands
Director Clubb Capital Ltd United Kingdom
Investor Relations Associate Crescendo IR United States
CEO CrystalsFirst GmbH Germany
Venture Partner CTI Life Sciences United States
CSO and VP New Ventures Danaher Life Sciences llc United Kingdom
CEO DC4U The Netherlands
Partner DeBere Capital Partners United Kingdom
CSO Delta 4 Austria
Chairman of the Board Delta4 Austria
CEO Delta4 Switzerland
CEO DepYMed United States
Scientific advisor DepYMed United States
CEO Destiny Pharma United Kingdom
Chairman DHP Private Equity, Hamburg Germany
CEO Dicot Sweden
Healtyhcare investment Director Downing Ventures United Kingdom
Chief Executive Officer Dyadic International United States
Managing Director of Business Development and Licensing Dyadic International Inc United States
CEO East Anglia Therapeutics United Kingdom
Partner EIP The Netherlands
Investment Manager Endeavour Vision Switzerland
Development/Investment Advisor Enterprise Ireland Ireland
partner Epidarex Capital United Kingdom
Partner Epidarex Capital United Kingdom
CEO Epiendo Iceland
COO EpiEndo Pharmaceuticals Iceland
CEO Evonetix Ltd United Kingdom
Chief Executive Officer Evox Therapeutics Ltd United Kingdom
CFO Flowsion A/S Denmark
Head of Business Development Forendo Pharma Ltd. Finland
Vice President FreeMind Group LLC United States
Associate Gilde healthcare The Netherlands
Chief Representative - Europe GL Capital China
Investment Associate Harbert European Growth Capital United Kingdom
Managing Director Health Equity Consulting United Kingdom
Director Hermes Partners Intl. Ltd. Hong Kong
Senior Investment Manager High-Tech Gründerfonds Germany
Investor Human Alfa Seed VC fund United Kingdom
MD Ignite Capital Partners, Inc. United Kingdom
Associate Illumina Ventures Ireland
CEO Immunicum AB Sweden
Chief Financial Officer Immunicum AB Sweden
Principal Imperial City Angels United Kingdom
Managing Director INKEF Capital The Netherlands
Analyst INKEF Capital The Netherlands
Director Inkef Capital BV The Netherlands
Innovation lead Innovate UK United Kingdom
CEO, Co-founder and Board Member Inositec Switzerland
CEO InteRNA Technologies The Netherlands
Investment Director & Partner Inveready Asset Management Spain
Chief Executive Officer IO Biotech ApS Denmark
Co-Founder and General Manager IOP GmbH Germany
Investment Analyst IP Group United Kingdom
Associate IPF Partners Switzerland
Partner IPF Partners Switzerland
Investment Manager IPF Partners Luxembourg
Technology Principal IQ Capital United Kingdom
Chief Executive Officer IXICO plc United Kingdom
SVP Sales & Marketing IXICO plc United Kingdom
General Partner JPIF Germany
Business Development Manager JSC Valenta Pharm Russia
Vice President Juvenescence United Kingdom
Co-Founder and Chief Executive Officer KaNDy Therapeutics United Kingdom
Chief Executive Officer Karma Oncology Limited United Kingdom
Investment Director Kinled United Kingdom
President Kissei America Japan
VP Kreos Capital United Kingdom
Venture Adviser Kurma Partners United Kingdom
Managing Partner Kurma Partners France
CEO Lempo Therapeutics Ltd. Israel
Chief Scientist Lightcast Discovery United Kingdom
CEO Lightcast Discovery United Kingdom
Chief Financial Officer and Chief Operating Officer Locate Bio Ltd United Kingdom
CEO LocateBio United Kingdom
MBA Candidate London Business School United Kingdom
Partner Longwall Ventures United Kingdom
Investment Director Longwall Ventures United Kingdom
Partner Lundbeckfonden Emerge Denmark
Senior Investment Director M Ventures The Netherlands
CEO Macrophage Pharma United Kingdom
Partner Marks & Clerk United Kingdom
CEO Medherant Ltd United Kingdom
Partner Medicxi United Kingdom
Business & Operations Manager Medtechtomarket United Kingdom
Director Medtechtomarket United Kingdom
Head of Corporate Advisory Mercia Asset Management United Kingdom
CEO Metabolomic Diagnostics Ireland
Co Founder Metabolomic Diagnostics Ltd Ireland
CFO MGB Biopharma Ltd United Kingdom
Chairman Micregen United Kingdom
CEO Micregen United Kingdom
Co Founder and Chief Executive Officer Microbiotica Ltd United Kingdom
CEO miDiagnostics nv Belgium
Chief Executive Officer MIP Diagnostics Ltd. United Kingdom
CEO Mission Therapeutics United Kingdom
CFO Mission Therapeutics United Kingdom
Chief Executive Officer Modus Therapeutics AB Sweden
Partner Momentum Biotech United Kingdom
CEO my personal therapeutics United Kingdom
Managing Director NCL Technology Ventures United Kingdom
Chief Executive Officer NeRRe Therapeutics United Kingdom
Principal New Enterprise Associates United States
Investor New Mosaic United Kingdom
Fund Manager New Science Global Healthcare Fund United Kingdom
CSO New Wave Ventures United Kingdom
Analyst Norgine Ventures United Kingdom
Senior Lead, Scouting & Partnerships Novateur Ventuers United Kingdom
President, Chief Executive Officer & Director Novian Health United States
VP Operations Novian Health United States
Venture Partner Novo Holdings United Kingdom
Partner Novo Ventures United Kingdom
Investment Manager and  and Senior Adviser Novotech and Alsa Holding United Kingdom
Chief Strategy and Development Officer OCT Clinical Trials United Kingdom
Angel OION United Kingdom
Director Optimum Strategic Communications United Kingdom
Senior Managing Director OrbiMed Israel
Head of Investor Relations Owlstone Medical Ltd. United Kingdom
Investor Own United Kingdom
Director Oxford Technology Management United Kingdom
Venture Partner Panacea Venture United Kingdom
partners Panakes Partners SgrSpa Italy
Chief Executive Officer & DirectorBiologics Paras Biopharmaceuticals Finland Oy Finland
Investment Director, Life Sciences Parkwalk Advisors United Kingdom
CEO Pep-Therapy France
Chief Executive Officer Pharmacytics The Netherlands
Partner Pontifax United Kingdom
CEO Primex Switzerland
Head EMEA Promidian United Kingdom
CEO ProteinLogic Ltd United Kingdom
Senior VP QBN Capital Hong Kong
Vice President, Global Partnering R-Pharm, RBV Capital United States
Investment Director Rainbow Seed Fund United Kingdom
Head, Business Development Rakuten Medical United States
Investment Manager Realia Family Office Russia
CEO Rexgenero United Kingdom
Associate RT Partners United Kingdom
CEO Scancell United Kingdom
Partner Seroba Life Sciences Ireland
Principal Seventure France
CEO Shield Therapeutics United Kingdom
CEO Silk Biomaterials srl Italy
BD Director Simcere Pharmaceutical Group United Kingdom
Director Business Development Simcere Pharmaceutical Group United Kingdom
Partner Sofinnova France
Partner Sofinnova Partners United Kingdom
BD Manager Solascure United Kingdom
Operations Director SolasCure United Kingdom
Analyst SOSV Ireland
Investment Director SPARK Impact United Kingdom
CFO Sprint  
CEO Sprint Bioscience AB Sweden
Chief Executive Officer Stelexis Therapeutics United States
Chief Executive Officer Surgify Medical Oy Finland
CEO Thrive Bioscience, Inc. United States
Managing partner Thuja Capital Management BV Belgium
Chief Business Officer TILT Biotherapeutics Ltd Finland
Venture Partner UCB Venture United Kingdom
Principal UCB Ventures United Kingdom
CEO UGA Biopharma GmbH Germany
Investment Manager UK Innovation & Science Seed Fund United Kingdom
CNS, W&M Health, Derma BD Head Valenta Pharma Russia
CEO Valo Therapeutics Ltd United Kingdom
Partner Ventac Partners United Kingdom
Partner Ventac Partners United Kingdom
Managing Partner Vesalius Biocapital Luxembourg
Senior Vice President Vulpes Investment Management Singapore
Co-founder and Portfolio Manager Vulpes Investment Management United Kingdom
Managing Partner Wellington Partners Life Science Venture Capital Consulting Germany
Managing Director Wharton Asset Management United Kingdom
Communications Director Wharton Asset Management United Kingdom
Chief Executive Officer Xbrane Biopharma Sweden
Partner, Investments Xeraya Capital Malaysia
Vice President Xeraya Capital Malaysia
CFO Zelluna Norway
Chief Executive Officer Zelluna Immunotherapy Norway